Turkey

Clinical context for turkey dosing

Turkey pharmacotherapy parallels chicken practice with notable differences in respiratory disease (turkeys are particularly susceptible to colibacillosis and ornithobacterium rhinotracheale), histomoniasis (caused by Histomonas meleagridis, with limited treatment options post-nitarsone withdrawal), and substantially larger body weights — dose-volume considerations for parenteral therapy in heritage and commercial-line birds differ.